Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
108 articles
Jaguar (JAGX) 2025 Earnings: Strategy and Investor Outlook
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Maze Therapeutics Stock Still Climbing After March Tumble
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Alumis Stock Over 300%: What Investors Should Know Now
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
MapLight's Just Sold 36,000: What It Means for Investors
When a chief financial officer liquidates shares, investors pay attention. This article digs into maplight's just sol...
Avita (RCEL) 2026 Earnings: Outlook & Insights for Investors
As investors scan the horizon for regenerative medicine players, Avita (RCEL) faces a pivotal quarter. This guide bre...
Celcuity (CELC) 2026 Earnings: What Investors Need
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
Related Topics
#Investing (86)
#Earnings Analysis (27)
#Stock Analysis (25)
#Stock Market News (13)
#Earnings (12)
#Stock Market (10)
#Insider Trading (10)
#Portfolio Management (8)
#Portfolio Strategy (8)
#risk-management (6)
#Hedge Funds (6)
#Investing Strategy (5)
#Pharmaceuticals (4)
#Investing Strategies (4)
#Investing Basics (3)